RMRP depletion hindered cell proliferation, induced cell apoptosis, and reduced TMZ resistance in glioma cells, and curbed the growth of TMZ-treated glioma xenograft tumors in vivo, hinting that RMRP loss or inhibition could be used to mitigate TMZ resistance. The gene discussed is RMRP; the disease is central nervous system cancer.